We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYEL icon
3351
Lyell Immunopharma
LYEL
$347M
$36K ﹤0.01%
1,243
+1,042
+518% +$49.6K
SPWR
3352
DELISTED
SunPower Corporation Common Stock
SPWR
$36K ﹤0.01%
12,175
+4,692
+63% +$12.8K
DTIL icon
3353
Precision BioSciences
DTIL
$205M
$36K ﹤0.01%
3,696
+3,307
+850% +$39K
MPX
3354
DELISTED
Marine Products Corp
MPX
$36K ﹤0.01%
3,560
+2,825
+384% +$30.4K
BTCO icon
3355
Invesco Galaxy Bitcoin ETF
BTCO
$425M
$35.9K ﹤0.01%
+600
New +$39.3K
INSE icon
3356
Inspired Entertainment
INSE
$163M
$35.7K ﹤0.01%
3,903
+3,685
+1,690% +$33.6K
OGN icon
3357
Organon & Co
OGN
$3.59B
$35.7K ﹤0.01%
1,725
-3,548
-67% -$70.5K
OLPX
3358
DELISTED
Olaplex Holdings
OLPX
$35.5K ﹤0.01%
23,064
-9,598
-29% -$15.3K
BCML icon
3359
BayCom
BCML
$341M
$35.5K ﹤0.01%
+1,745
New +$34.7K
ENB icon
3360
Enbridge
ENB
$112B
$35.4K ﹤0.01%
995
-81,639
-99% -$2.92M
AURA icon
3361
Aura Biosciences
AURA
$802M
$35.4K ﹤0.01%
4,682
+1,528
+48% +$11.2K
ORIC icon
3362
Oric Pharmaceuticals
ORIC
$1.43B
$35.4K ﹤0.01%
5,003
+4,253
+567% +$38.1K
ATOS icon
3363
Atossa Therapeutics
ATOS
$23.5M
$35.4K ﹤0.01%
+1,981
New +$43.8K
UTMD icon
3364
Utah Medical Products
UTMD
$230M
$35.3K ﹤0.01%
528
+507
+2,414% +$34.5K
INNV icon
3365
InnovAge Holding
INNV
$1.42B
$35.3K ﹤0.01%
7,108
+2,710
+62% +$11.8K
NAGE
3366
Niagen Bioscience
NAGE
$242M
$35.2K ﹤0.01%
12,878
+12,778
+12,778% +$42.8K
EAF icon
3367
GrafTech
EAF
$201M
$35.1K ﹤0.01%
3,622
+2,989
+472% +$46K
RSVR
3368
Reservoir Media
RSVR
$646M
$35.1K ﹤0.01%
4,437
+4,183
+1,647% +$33.4K
AGM.A icon
3369
Federal Agricultural Mortgage Class A
AGM.A
$1.79B
$35K ﹤0.01%
276
+213
+338% +$29.9K
GSBD icon
3370
Goldman Sachs BDC
GSBD
$1.08B
$34.9K ﹤0.01%
2,322
-10,025
-81% -$154K
GLAD icon
3371
Gladstone Capital
GLAD
$444M
$34.9K ﹤0.01%
+1,499
New +$32.7K
CNTY icon
3372
Century Casinos
CNTY
$34.3M
$34.8K ﹤0.01%
12,578
+6,801
+118% +$19.7K
STRO icon
3373
Sutro Biopharma
STRO
$353M
$34.8K ﹤0.01%
1,188
+726
+157% +$28.7K
TYRA icon
3374
Tyra Biosciences
TYRA
$1.51B
$34.8K ﹤0.01%
2,177
+2,033
+1,412% +$35K
ECO
3375
Okeanis Eco Tankers
ECO
$2.46B
$34.6K ﹤0.01%
1,077
+1,070
+15,286% +$34.7K

Similar funds

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.